Intake Agent
AI agent that embeds in referral pathways to onboard patients and handle FAQs
Company profile
Clinical AI for mental healthcare providers
Company profile
Limbic is a clinical AI company specializing in mental healthcare solutions for health plans, behavioral health providers, health systems, and NHS Talking Therapies services. The company has developed proprietary AI agents that integrate into existing care workflows to address the growing gap between demand and capacity in behavioral health services. With over 1.6 billion people in need of care and only 2.5 million clinicians available, Limbic's technology helps scale access without sacrificing quality. Limbic's flagship products include Limbic Access, a clinical AI assistant for patient intakes and assessments that embeds in referral pathways, and Limbic Care, an AI companion providing on-demand support and CBT therapy through generative chat. The company's proprietary clinical AI sits between users and large language models to ensure all decisions are based on validated clinical guidance. Limbic is the only mental health AI chatbot with Class IIa medical device certification in the UK, demonstrating its commitment to clinical precision and patient safety. The platform has directly supported over 650,000 patients across care pathways at leading health plans and health systems in the US and UK. Clinical evidence published in Nature Medicine shows significant improvements in access for underserved populations, with customers experiencing a 179% increase in nonbinary individuals seeking care, 29% increase in minority referrals, 2x recovery rates, and 23% lower dropout rates. The company's technology is HIPAA and GDPR compliant, ISO 27001 certified, and interoperable with multiple EHR systems.
Company description Limbic official website
Mission. Limbic brings clinical-grade AI to restore balance. We expand capacity without sacrificing care.
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Cloud Saas deployment with recorded integration context.
Recorded integration context: Multiple EHR systems (specific names not disclosed), Patient management systems, PCMIS.
Company milestones
Upgraded Limbic Care to include regulated AI scribe technology for NHS mental health services (June 2026). Supported over 650,000 patients across care pathways. Published landmark Nature Medicine study. First AI chatbot to earn UK Class IIa medical device status.
Partnerships
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
AI agent that embeds in referral pathways to onboard patients and handle FAQs
Clinical AI assistant for patient intakes and assessments in mental healthcare
Clinical AI companion for on-demand support and AI scribe technology
Delivers CBT through generative chat with escalation pathways to clinical staff
Proprietary clinical AI that assesses needs, predicts diagnoses, and triages to the right level of care
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
No linked records are currently available.
Clinical validation
No linked records are currently available.
Regulatory
No linked records are currently available.
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Increased access for underserved populations
Compared to standard care pathways
Patient retention in treatment
Compared to traditional care delivery
Improved engagement
Rogers Behavioral Health AI-screened intake vs web submissions
After therapy with Limbic
Determining correct ADSMs (assessment measures)
Rogers Behavioral Health
Nature Medicine study across customer base
Reimagining patient intake and access to mental health services by embedding clinical-grade AI into workflows
3x higher admit rate from AI-screened intake vs. web submissions, 90.5% positive patient satisfaction, 108% increase in access for diverse groups
Increasing access to mental health services, reducing dropout rates, and reaching hard-to-access groups including BAME, LGBTQ+, and older adults
Referrals increased from 6,900 to over 8,000 in six months, BAME referrals up from 2,000 to 2,200, LGBTQ+ referrals up from 400 to 700, 93% accuracy in determining correct ADSMs, reduced two-week wait time for assessment
Expanding access to mental health services with clinical AI
Expanded access to care
Digital transformation to increase referrals and reduce therapist burnout
32% increase in referrals, reduced therapist burnout
Supporting staff with AI technology
Improved staff support
Using clinical AI to increase capacity and reduce clinician workloads
Increased capacity and reduced workloads
05 · Leadership
Leadership profiles and professional links from the current Company record.
Ross Harper
Founder & CEO
Thevindu Edirisinghe
Product
Remus Poon
Machine Learning Engineer
Sebastiaan de Vries
Founder & CTO
Jeremy Stunt
Chief Escape Officer
Josh Cable-May
Head of Clinical
Martin Galton
Director - Freelance strategist and marketing consultant
06 · Company updates
Recent articles published on Limbic's official website.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies providing AI-powered mental health support, therapy platforms, mental wellness tracking, psychiatric care, digital therapeutics for mental health conditions, or AI-driven mental health screening and monitoring. Includes XR-based therapy, AI mental health screening infrastructure, and platforms supporting behavioral health for individuals and health systems.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.